The U.S. Military HIV Research Program (MHRP) was established in 1985 to protect U.S. troops entering endemic HIV areas and is dedicated to HIV vaccine development, prevention, disease surveillance, and HIV care and treatment. NIAID plans and executes HIV/AIDS research projects annually with MHRP through an interagency agreement on HIV vaccine research.
Main Areas of Focus
- To protect the U.S. Military from HIV
- To improve global health by conducting research to develop an HIV vaccine, reduce new infections and find a cure
The Interagency Agreement (IAA) between NIAID/DAIDS and US Military Research and Materiel Command (MRMC), which oversees MHRP, is negotiated annually. NIAID provides funding for research and support for projects deemed scientifically important to its mission. The IAA is drafted by DAIDS Vaccine Research Program (VRP) with input from DAIDS Treatment Research Program (TRP), NIMH Division of AIDS Research, and NIAID Office of the Director. The Vaccine Interagency Management and Oversight Committee (VIMOC), co-chaired by the VRP and TRP directors and the MHRP director, meets annually prior to development of the draft IAA to discuss research and funding. In addition to DAIDS VRP and TRP, other stakeholders included in the VIMOC are NIMH DAR, DAIDS OD, and MHRP.
Read more about this network: U.S. Military HIV Research Program (MHRP)
6720A Rockledge Drive Suite 400
Bethesda, MD 20817
There are multiple MHRP locations both domestic and abroad.